This is in line with the original Ridker’s hypothesis, from 2016, to identify novel biomarkers of atherosclerosis and targets of athero-protection by moving upstream CRP release, along the inflammasome signalling IL-1/IL-6 axis (Ridker, 2016). This evidence concerns the gene IL1B and atherosclerosis.